Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.
Passalacqua S, Ferraro PM, Bresci G, D'Ovidio V, Astegiano M, Principi M, Testa R, D'Incà R, Valpiani D, Armuzzi A, Sablich R, Cavallaro F, Costa F, Di Leo V, Colombo E, Santini A, Aratari A, Lecis P, Saladino V, Riegler G, Marco M, Calella F, Ricci C, Guidi ML, Repaci G, Silla M. Passalacqua S, et al. Among authors: riegler g. J Clin Apher. 2011 Dec;26(6):332-7. doi: 10.1002/jca.20315. Epub 2011 Nov 9. J Clin Apher. 2011. PMID: 22072543
[Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data].
Ferraro PM, D'Ovidio V, Bresci G, Astegiano M, Principi B, D'Inca' R, Testa R, Valpiani D, Guidi L, Armuzzi A, Costa F, Aratari A, Vecchi M, De Franchis R, Di Leo V, Ricci C, Riegler G, Colombo E, Repaci G, Lecis P, Silla M, Passalacqua S. Ferraro PM, et al. Among authors: riegler g. G Ital Nefrol. 2012 Jan-Feb;29 Suppl 54:S144-6. G Ital Nefrol. 2012. PMID: 22388848 Italian.
Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
Biancone L, Armuzzi A, Scribano ML, Castiglione F, D'Incà R, Orlando A, Papi C, Daperno M, Vecchi M, Riegler G, Fries W, Alvisi P, Meucci G, Mocciaro F, Rogai F, Festa S, Guidi L, Testa A, Spina L, Renna S, Viola A, Patturelli M, Di Mitri R, Frankovic I, Calabrese E, Petruzziello C, De Cristofaro E, Sena G, Ruffa A, Neri B, Rossi A. Biancone L, et al. Among authors: riegler g. Inflamm Bowel Dis. 2020 Feb 11;26(3):450-459. doi: 10.1093/ibd/izz155. Inflamm Bowel Dis. 2020. PMID: 31498388
Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial.
Vernia P, Annese V, Bresci G, d'Albasio G, D'Incà R, Giaccari S, Ingrosso M, Mansi C, Riegler G, Valpiani D, Caprilli R; Gruppo Italiano per lo Studio del Colon and del Retto. Vernia P, et al. Among authors: riegler g. Eur J Clin Invest. 2003 Mar;33(3):244-8. doi: 10.1046/j.1365-2362.2003.01130.x. Eur J Clin Invest. 2003. PMID: 12641543 Clinical Trial.
Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006.
Bortoli A, Pedersen N, Duricova D, D'Inca R, Gionchetti P, Panelli MR, Ardizzone S, Sanroman AL, Gisbert JP, Arena I, Riegler G, Marrollo M, Valpiani D, Corbellini A, Segato S, Castiglione F, Munkholm P; European Crohn-Colitis Organisation (ECCO) Study Group of Epidemiologic Committee (EpiCom). Bortoli A, et al. Among authors: riegler g. Aliment Pharmacol Ther. 2011 Oct;34(7):724-34. doi: 10.1111/j.1365-2036.2011.04794.x. Epub 2011 Aug 4. Aliment Pharmacol Ther. 2011. PMID: 21815900 Free article.
Polymorphisms of tumor necrosis factor-alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease.
Cucchiara S, Latiano A, Palmieri O, Canani RB, D'Incà R, Guariso G, Vieni G, De Venuto D, Riegler G, De'Angelis GL, Guagnozzi D, Bascietto C, Miele E, Valvano MR, Bossa F, Annese V; Italian Society of Pediatric Gastroenterology and Nutrition. Cucchiara S, et al. Among authors: riegler g. J Pediatr Gastroenterol Nutr. 2007 Feb;44(2):171-9. doi: 10.1097/MPG.0b013e31802c41f3. J Pediatr Gastroenterol Nutr. 2007. PMID: 17255827
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease.
Cottone M, Kohn A, Daperno M, Armuzzi A, Guidi L, D'Inca R, Bossa F, Angelucci E, Biancone L, Gionchetti P, Ardizzone S, Papi C, Fries W, Danese S, Riegler G, Cappello M, Castiglione F, Annese V, Orlando A. Cottone M, et al. Among authors: riegler g. Clin Gastroenterol Hepatol. 2011 Jan;9(1):30-5. doi: 10.1016/j.cgh.2010.09.026. Epub 2010 Oct 15. Clin Gastroenterol Hepatol. 2011. PMID: 20951835
Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study.
Bertomoro P, Renna S, Cottone M, Riegler G, Bossa F, Giglio L, Pastorelli L, Papi C, Castiglione F, Angelucci E, Pica R, Di Paolo MC, D'Incà R. Bertomoro P, et al. Among authors: riegler g. J Crohns Colitis. 2010 Sep;4(3):291-300. doi: 10.1016/j.crohns.2009.12.009. Epub 2010 Jan 18. J Crohns Colitis. 2010. PMID: 21122518
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).
Biancone L, Annese V, Ardizzone S, Armuzzi A, Calabrese E, Caprioli F, Castiglione F, Comberlato M, Cottone M, Danese S, Daperno M, D'Incà R, Frieri G, Fries W, Gionchetti P, Kohn A, Latella G, Milla M, Orlando A, Papi C, Petruzziello C, Riegler G, Rizzello F, Saibeni S, Scribano ML, Vecchi M, Vernia P, Meucci G; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Biancone L, et al. Among authors: riegler g. Dig Liver Dis. 2017 Apr;49(4):338-358. doi: 10.1016/j.dld.2017.01.141. Epub 2017 Jan 17. Dig Liver Dis. 2017. PMID: 28161290
160 results